Predictors of International Normalized Ratio Variability in Patients With Atrial Fibrillation Under Warfarin Therapy

  • Numao Yoshimi
    Department of Cardiovascular Medicine, The Cardiovascular Institute
  • Suzuki Shinya
    Department of Cardiovascular Medicine, The Cardiovascular Institute
  • Arita Takuto
    Department of Cardiovascular Medicine, The Cardiovascular Institute
  • Yagi Naoharu
    Department of Cardiovascular Medicine, The Cardiovascular Institute
  • Otsuka Takayuki
    Department of Cardiovascular Medicine, The Cardiovascular Institute
  • Sagara Koichi
    Department of Cardiovascular Medicine, The Cardiovascular Institute
  • Semba Hiroaki
    Department of Cardiovascular Medicine, The Cardiovascular Institute
  • Sasaki Kenichi
    Department of Cardiovascular Surgery, The Cardiovascular Institute
  • Kano Hiroto
    Department of Cardiovascular Medicine, The Cardiovascular Institute
  • Matsuno Shunsuke
    Department of Cardiovascular Medicine, The Cardiovascular Institute
  • Kato Yuko
    Department of Cardiovascular Medicine, The Cardiovascular Institute
  • Uejima Tokuhisa
    Department of Cardiovascular Medicine, The Cardiovascular Institute
  • Oikawa Yuji
    Department of Cardiovascular Medicine, The Cardiovascular Institute
  • Nagashima Kazuyuki
    Department of Cardiovascular Medicine, The Cardiovascular Institute
  • Kirigaya Hajime
    Department of Cardiovascular Medicine, The Cardiovascular Institute
  • Kunihara Takashi
    Department of Cardiovascular Surgery, The Cardiovascular Institute
  • Yajima Junji
    Department of Cardiovascular Medicine, The Cardiovascular Institute
  • Aizawa Tadanori
    Department of Cardiovascular Medicine, The Cardiovascular Institute
  • Yamashita Takeshi
    Department of Cardiovascular Medicine, The Cardiovascular Institute

Search this article

Abstract

<p>Background:Variability in the international normalized ratio (INR) of prothrombin time has been suggested to be related to outcome in patients with atrial fibrillation (AF) under warfarin therapy, but its determinants remain unclear.</p><p>Methods and Results:The study population consisted of 626 AF patients under warfarin therapy in the Shinken Database (n=22,230). INR variability was calculated by Fihn’s method. Determinants of high log INR variability (defined as over mean+standard deviation) were determined by logistic regression analyses. Symptomatic heart failure (odds ratio [OR] 3.974, 95% confidence interval [CI] 2.510–6.292), older age (≥75 years old; OR 2.984, 95% CI 1.844–4.826) and severe renal dysfunction (eGFR <30 mL/min/1.73 m2; OR 3.918, 95% CI 1.742–8.813) were identified as independent predictors of high INR variability on multivariate logistic regression analysis.</p><p>Conclusions:The determinants of INR variability in AF patients under warfarin therapy could assist Japanese clinicians in identifying patients likely to show unstable warfarin control irrespective of the definition of the target INR range.</p>

Journal

Citations (2)*help

See more

References(29)*help

See more

Details 詳細情報について

Report a problem

Back to top